(Q42550971)

2 November 2017

title

Synthetic soluble analogs of galactosylceramide (GalCer) bind to the V3 domain of HIV-1 gp120 and inhibit HIV-1-induced fusion and entry (English)

1 reference

2 November 2017

Fantini J

1

1 reference

2 November 2017

Hammache D

2

1 reference

2 November 2017

Delézay O

3

1 reference

2 November 2017

Yahi N

4

1 reference

2 November 2017

André-Barrès C

5

1 reference

2 November 2017

Rico-Lattes I

6

1 reference

2 November 2017

Lattes A

7

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 March 1997

1 reference

Journal of Biological Chemistry

2 November 2017

published in

1 reference

2 November 2017

volume

272

1 reference

2 November 2017

issue

11

1 reference

2 November 2017

page(s)

7245-7252

1 reference

Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1.

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.7245

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.7245

Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.7245

Identification of Conserved Residues in the Human Immunodeficiency Virus Type 1 Principal Neutralizing Determinant That Are Involved in Fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.7245

Tryptase TL2in the membrane of human T4+lymphocytes is a novel binding protein of the V3 domain of HIV-1 envelope glycoprotein gp120

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.7245

Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.7245

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.7245

Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.7245

Antiviral agents: characteristic activity spectrum depending on the molecular target with which they interact.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.7245

Inhibition of Entry of HIV-1 in Neural Cell Lines by Antibodies Against Galactosyl Ceramide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.7245

Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.7245

Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.7245

An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.7245

Binding of human immunodeficiency virus type I (HIV-1) gp120 to galactosylceramide (GalCer): relationship to the V3 loop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.7245

Identification of the envelope V3 loop as a determinant of a CD4-negative neuronal cell tropism for HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.11.7245

21 January 2018

Identifiers

DOI

10.1074/JBC.272.11.7245

1 reference

2 November 2017

1 reference